News and Announcements
PrIME’s Competitive Advantage
- Published September 06, 2012 2:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PrIME technology is a disruptive platform technology that can be applied to the separation of any charged body that exists in liquid form and is superior to pressure-based separation technologies currently in commercial use.
PrIME Biologics’ entry into the Asian plasma products market is not in competition with existing manufacturers. Instead, PrIME is creating a new lower price point market segment in the Asian market by using Currently Unprocessable Plasma (CUP), which is currently discarded.
——-
To view the full article, please click the link below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
